|
Volumn 92, Issue 18, 1995, Pages 8210-8214
|
Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors
a b c b b d e a b c,f d
f
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIVIRAL ACTIVITY;
ARTICLE;
CELL SPECIFICITY;
CHIMERA;
CONTROLLED STUDY;
DRUG RESISTANCE;
ENZYME ACTIVITY;
ENZYME INHIBITION;
HUMAN IMMUNODEFICIENCY VIRUS 1;
NONHUMAN;
PRIORITY JOURNAL;
RETROVIRUS;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
AMINO ACID SEQUENCE;
ANIMAL;
ANTIVIRAL AGENTS;
BASE SEQUENCE;
CELL LINE;
DISEASE MODELS, ANIMAL;
DNA PRIMERS;
HIV-1;
HIV-1 REVERSE TRANSCRIPTASE;
MACACA FASCICULARIS;
MACACA MULATTA;
MOLECULAR SEQUENCE DATA;
PYRIDINES;
REVERSE TRANSCRIPTASE INHIBITORS;
SIV;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, P.H.S.;
ZIDOVUDINE;
ANIMALIA;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
MACACA;
SIMIAE;
SIMIAN IMMUNODEFICIENCY VIRUS;
UNIDENTIFIED RETROVIRUS;
|
EID: 0029085036
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.92.18.8210 Document Type: Article |
Times cited : (113)
|
References (38)
|